Miyamoto K, Nakamura T, Nagataki S, Tomita N, Kitajima K
School of Health Sciences, Okayama University.
Jpn J Cancer Res. 1992 May;83(5):415-7. doi: 10.1111/j.1349-7006.1992.tb01943.x.
Syncytium inhibition assay to distinguish between HTLV-I and HTLV-II infection was performed with sera and cerebrospinal fluid of 15 HTLV-I-associated myelopathy (HAM) patients. Also, genome analysis of HTLV-II proviral DNA was performed in some HAM patients by use of the polymerase chain reaction method. All of the HAM patients were negative for co-infection with HTLV-II.
采用15例成人T细胞白血病病毒I型相关脊髓病(HAM)患者的血清和脑脊液进行了区分成人T细胞白血病病毒I型(HTLV-I)和成人T细胞白血病病毒II型(HTLV-II)感染的合胞体抑制试验。此外,还对部分HAM患者采用聚合酶链反应法进行了HTLV-II前病毒DNA的基因组分析。所有HAM患者均未合并HTLV-II感染。